Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · Real-Time Price · USD
57.33
-0.80 (-1.38%)
At close: Oct 28, 2025, 4:00 PM EDT
57.46
+0.13 (0.23%)
After-hours: Oct 28, 2025, 7:11 PM EDT
Lantheus Holdings Revenue
Lantheus Holdings had revenue of $378.05M in the quarter ending June 30, 2025, a decrease of -4.07%. This brings the company's revenue in the last twelve months to $1.52B, up 5.75% year-over-year. In the year 2024, Lantheus Holdings had annual revenue of $1.53B with 18.32% growth.
Revenue (ttm)
$1.52B
Revenue Growth
+5.75%
P/S Ratio
2.60
Revenue / Employee
$1,881,996
Employees
808
Market Cap
3.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.53B | 237.48M | 18.32% |
| Dec 31, 2023 | 1.30B | 361.37M | 38.65% |
| Dec 31, 2022 | 935.06M | 509.85M | 119.91% |
| Dec 31, 2021 | 425.21M | 85.80M | 25.28% |
| Dec 31, 2020 | 339.41M | -7.93M | -2.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
LNTH News
- 16 hours ago - SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus - PRNewsWire
- 1 day ago - LANTHEUS HOLDINGS, INC. (NASDAQ: LNTH) DEADLINE ALERT Bernstein Liebhard LLP Reminds Lantheus Holdings, Inc. Investors of Upcoming Deadline - GlobeNewsWire
- 5 days ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus - PRNewsWire
- 5 days ago - Lantheus to Host Third Quarter 2025 Earnings Conference Call and Webcast on November 6, 2025, at 8:00 a.m. Eastern Time - GlobeNewsWire
- 13 days ago - LANTHEUS DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Reminds Lantheus Holdings Investors to Contact the Firm Before the November 10th Deadline - GlobeNewsWire
- 14 days ago - Lantheus Holdings: Not An Easy Buy, But The Company Continues To Create Value - Seeking Alpha
- 16 days ago - LNTH INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus - GlobeNewsWire
- 22 days ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of November 10, 2025 in Lantheus Holdings, Inc. Lawsuit - LNTH - PRNewsWire